
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets
Zoya Serebrovska, Elisa Chong, Tatiana V. Serebrovskaya, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 12, pp. 1539-1546
Open Access | Times Cited: 185
Zoya Serebrovska, Elisa Chong, Tatiana V. Serebrovskaya, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 12, pp. 1539-1546
Open Access | Times Cited: 185
Showing 1-25 of 185 citing articles:
Neutrophils in COVID-19
Nico Reusch, Elena De Domenico, Lorenzo Bonaguro, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 251
Nico Reusch, Elena De Domenico, Lorenzo Bonaguro, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 251
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Zhen Luo, Mingfu Tian, Ge Yang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 220
Zhen Luo, Mingfu Tian, Ge Yang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 220
Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
José Pórtoles, Leyre Martín Rodríguez, José Jesús Broseta, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 217
José Pórtoles, Leyre Martín Rodríguez, José Jesús Broseta, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 217
Skeletal muscle alterations in patients with acute Covid‐19 and post‐acute sequelae of Covid‐19
M Soares, Moritz Eggelbusch, Elie Naddaf, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 1, pp. 11-22
Open Access | Times Cited: 192
M Soares, Moritz Eggelbusch, Elie Naddaf, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 1, pp. 11-22
Open Access | Times Cited: 192
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112420-112420
Open Access | Times Cited: 99
Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112420-112420
Open Access | Times Cited: 99
Neuropathologic findings of patients with COVID-19: a systematic review
Azalea T. Pajo, Adrian I. Espiritu, Almira Doreen Abigail O. Apor, et al.
Neurological Sciences (2021) Vol. 42, Iss. 4, pp. 1255-1266
Open Access | Times Cited: 79
Azalea T. Pajo, Adrian I. Espiritu, Almira Doreen Abigail O. Apor, et al.
Neurological Sciences (2021) Vol. 42, Iss. 4, pp. 1255-1266
Open Access | Times Cited: 79
Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID
Erin Clough, Joseph R. Inigo, Dhyan Chandra, et al.
Journal of Neuroimmune Pharmacology (2021) Vol. 16, Iss. 4, pp. 770-784
Open Access | Times Cited: 64
Erin Clough, Joseph R. Inigo, Dhyan Chandra, et al.
Journal of Neuroimmune Pharmacology (2021) Vol. 16, Iss. 4, pp. 770-784
Open Access | Times Cited: 64
The Role of Acidosis in the Pathogenesis of Severe Forms of COVID-19
Yury D. Nechipurenko, Denis Semyonov, I. A. Lavrinenko, et al.
Biology (2021) Vol. 10, Iss. 9, pp. 852-852
Open Access | Times Cited: 62
Yury D. Nechipurenko, Denis Semyonov, I. A. Lavrinenko, et al.
Biology (2021) Vol. 10, Iss. 9, pp. 852-852
Open Access | Times Cited: 62
Changes in Glycolytic Pathway in SARS-COV 2 Infection and Their Importance in Understanding the Severity of COVID-19
Adalberto Santos, Pedro Póvoa, Paulo Paixão, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 59
Adalberto Santos, Pedro Póvoa, Paulo Paixão, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 59
Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 47
Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 47
The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2051-2051
Open Access | Times Cited: 43
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2051-2051
Open Access | Times Cited: 43
Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke
Asma W. Al-Thomali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2032-2032
Open Access | Times Cited: 38
Asma W. Al-Thomali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2032-2032
Open Access | Times Cited: 38
A flexible optoacoustic blood ‘stethoscope’ for noninvasive multiparametric cardiovascular monitoring
Haoran Jin, Zesheng Zheng, Zequn Cui, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Haoran Jin, Zesheng Zheng, Zequn Cui, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Root Causes of Fungal Coinfections in COVID-19 Infected Patients
Arman Amin, Artin Vartanian, Nicole Poladian, et al.
Infectious Disease Reports (2021) Vol. 13, Iss. 4, pp. 1018-1035
Open Access | Times Cited: 41
Arman Amin, Artin Vartanian, Nicole Poladian, et al.
Infectious Disease Reports (2021) Vol. 13, Iss. 4, pp. 1018-1035
Open Access | Times Cited: 41
Cardiovascular disease in SARS‐CoV‐2 infection
Kei Sato, Jane E. Sinclair, Habib Sadeghirad, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 9
Open Access | Times Cited: 40
Kei Sato, Jane E. Sinclair, Habib Sadeghirad, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 9
Open Access | Times Cited: 40
Hesperetin as an anti-SARS-CoV-2 agent can inhibit COVID-19-associated cancer progression by suppressing intracellular signaling pathways
Hamidreza Zalpoor, Maryam Bakhtiyari, Hooriyeh Shapourian, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1533-1539
Open Access | Times Cited: 35
Hamidreza Zalpoor, Maryam Bakhtiyari, Hooriyeh Shapourian, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1533-1539
Open Access | Times Cited: 35
Quercetin potential effects against SARS‐CoV ‐2 infection and COVID ‐19‐associated cancer progression by inhibiting mTOR and hypoxia‐inducible factor‐1α (HIF ‐1α)
Hamidreza Zalpoor, Maryam Bakhtiyari, Mahsa Liaghat, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 7, pp. 2679-2682
Open Access | Times Cited: 31
Hamidreza Zalpoor, Maryam Bakhtiyari, Mahsa Liaghat, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 7, pp. 2679-2682
Open Access | Times Cited: 31
High-altitude is associated with better short-term survival in critically ill COVID-19 patients admitted to the ICU
Katherine Simbaña‐Rivera, Pablo R. Morocho Jaramillo, Javier V. Velastegui Silva, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0262423-e0262423
Open Access | Times Cited: 31
Katherine Simbaña‐Rivera, Pablo R. Morocho Jaramillo, Javier V. Velastegui Silva, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0262423-e0262423
Open Access | Times Cited: 31
Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches
Fee Faysal Ahmed, Md. Selim Reza, Md. Shahin Sarker, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266124-e0266124
Open Access | Times Cited: 29
Fee Faysal Ahmed, Md. Selim Reza, Md. Shahin Sarker, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266124-e0266124
Open Access | Times Cited: 29
Acriflavine, an Acridine Derivative for Biomedical Application: Current State of the Art
Kinga Piorecka, Jan Kurjata, Włodzimierz A. Stańczyk
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11415-11432
Open Access | Times Cited: 28
Kinga Piorecka, Jan Kurjata, Włodzimierz A. Stańczyk
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11415-11432
Open Access | Times Cited: 28
Metabolic Reprogramming in SARS-CoV-2 Infection Impacts the Outcome of COVID-19 Patients
Laura E. Martínez-Gómez, Isabel Ibarra‐González, Cynthia Fernández‐Lainez, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Laura E. Martínez-Gómez, Isabel Ibarra‐González, Cynthia Fernández‐Lainez, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Hypoxia-Inducible Factor 1α and Its Role in Lung Injury: Adaptive or Maladaptive
Madathilparambil V. Suresh, Sanjay Balijepalli, Sumeet Solanki, et al.
Inflammation (2023) Vol. 46, Iss. 2, pp. 491-508
Open Access | Times Cited: 20
Madathilparambil V. Suresh, Sanjay Balijepalli, Sumeet Solanki, et al.
Inflammation (2023) Vol. 46, Iss. 2, pp. 491-508
Open Access | Times Cited: 20
Cortical-blood vessel assembloids exhibit Alzheimer’s disease phenotypes by activating glia after SARS-CoV-2 infection
Dasom Kong, Ki Hoon Park, Da‐Hyun Kim, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Dasom Kong, Ki Hoon Park, Da‐Hyun Kim, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions
Yong Qiu, Chunheng Mo, Lu Chen, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 5
Yong Qiu, Chunheng Mo, Lu Chen, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 5